Filing Details
- Accession Number:
- 0001562180-19-000071
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-01-02 16:32:13
- Reporting Period:
- 2018-12-27
- Accepted Time:
- 2019-01-02 16:32:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1100412 | Array Biopharma Inc | ARRY | Pharmaceutical Preparations (2834) | 841460811 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1620368 | Victor Sandor | C/O Array Biopharma Inc. 3200 Walnut Street Boulder CO 80301 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-12-27 | 6,268 | $14.05 | 228,998 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- These trades were made pursuant to a Rule 10b5-1 trading plan.
- The price reported for these shares is the weighted average sale price of transactions made at prices from $14.00 to $14.25. Details of actual prices for shares sold are available from the Issuer upon request.
Billionaire Hedge Funds
